Literature DB >> 9310840

Normal thymic selection, superantigen-induced deletion and Fas-mediated apoptosis of T cells in IL-2 receptor beta chain-deficient mice.

H Suzuki1, A Hayakawa, D Bouchard, I Nakashima, T W Mak.   

Abstract

Mice lacking the IL-2 receptor beta chain (IL-2R beta) exhibit an autoimmune reaction characterized by generalized T cell activation, production of autoantibodies, myeloproliferation and severe anemia. T cells of IL-2R beta-/- mice were examined to elucidate the mechanism responsible for their abnormal activation and to determine how such abnormal activation might affect other cell lineages. Elevated levels of IgG, IgE and autoantibodies in IL-2R beta-/- mice were found to be associated with activated CD4+ T cells which secreted elevated levels of IL-4. Thymocytes in IL-2R beta-/- mice showed normal negative and positive selection patterns when analyzed in transgenic mice bearing a TCR specific for HY antigen, suggesting that neither IL-2 nor IL-15 is essential for thymic selection. Peripheral T cells in IL-2R beta-deficient mice underwent normal programmed cell death in response to staphylococcal enterotoxin B superantigen, in contrast to cells from mice deficient for either IL-2 or IL-2R alpha. Activated T cells in IL-2R beta-deficient mice expressed normal levels of Fas antigen and underwent normal apoptosis in response to induction with anti-Fas mAb. Thus, the accumulation of activated T cells in IL-2R beta-/- mice does not appear to be derived from abnormalities in either thymic selection or Fas-mediated apoptosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9310840     DOI: 10.1093/intimm/9.9.1367

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  8 in total

Review 1.  Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3+ regulatory T cells.

Authors:  Mark D Mannie; Kayla B DeOca; Alexander G Bastian; Cody D Moorman
Journal:  Cell Immunol       Date:  2020-07-15       Impact factor: 4.868

2.  Functional dissection of the cytoplasmic subregions of the IL-2 receptor betac chain in primary lymphocyte populations.

Authors:  H Fujii; K Ogasawara; H Otsuka; M Suzuki; K Yamamura; T Yokochi; T Miyazaki; H Suzuki; T W Mak; S Taki; T Taniguchi
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

3.  Inhibition of Fas-mediated apoptotic cell death of murine T lymphocytes in a mouse model of immunosenescence in linkage to deterioration in cell membrane raft function.

Authors:  Toshihiro Yokoyama; Jun Du; Yoshiyuki Kawamoto; Haruhiko Suzuki; Izumi Nakashima
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

4.  IL-2 family of cytokines in T regulatory cell development and homeostasis.

Authors:  Thomas R Malek; Aixin Yu; Linjian Zhu; Takaji Matsutani; Dennis Adeegbe; Allison L Bayer
Journal:  J Clin Immunol       Date:  2008-08-26       Impact factor: 8.317

5.  A novel role of IL-2 in organ-specific autoimmune inflammation beyond regulatory T cell checkpoint: both IL-2 knockout and Fas mutation prolong lifespan of Scurfy mice but by different mechanisms.

Authors:  Lingjie Zheng; Rahul Sharma; Felicia Gaskin; Shu Man Fu; Shyr-Te Ju
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

6.  Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis.

Authors:  Muhaimin Rifa'i; Yoshiyuki Kawamoto; Izumi Nakashima; Haruhiko Suzuki
Journal:  J Exp Med       Date:  2004-11-01       Impact factor: 14.307

7.  Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice.

Authors:  M K Kennedy; M Glaccum; S N Brown; E A Butz; J L Viney; M Embers; N Matsuki; K Charrier; L Sedger; C R Willis; K Brasel; P J Morrissey; K Stocking; J C Schuh; S Joyce; J J Peschon
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

8.  Normal regulatory alpha/beta T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor beta in vivo.

Authors:  H Suzuki; Y W Zhou; M Kato; T W Mak; I Nakashima
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.